Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
18.09.24 | FlyPharma Europe, Vienna - October 2024 conference | ||
17.09.24 | UKRI's MRC awards £27.4m to University of Dundee research unit | ||
16.09.24 | WHO adds first mpox vaccine to prequalification list | ||
13.09.24 | World Sepsis Day 2024 highlights need for better sepsis treatments | ||
13.09.24 | Nxera and Cancer Research UK to present promising cancer drug trial at ESMO | ||
12.09.24 | HRT linked to reduced psychosis relapse risk in menopausal women | ||
12.09.24 | Centessa reports positive phase 1 clinical data for ORX750 | ||
11.09.24 | Scotland first in UK to approve new myeloma treatment | ||
11.09.24 | AI-Powered chest X-Rays detect lung cancer early | ||
10.09.24 | Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease | ||
10.09.24 | APL and CurifyLabs partner to support patients with 3D printing medicine technology | ||
09.09.24 | ChatGPT outperforms trainee doctors in assessing respiratory illness in children | ||
06.09.24 | Eli Lilly's once-weekly insulin shows promise in phase 3 trials | ||
05.09.24 | AMBLor prognostic melanoma biomarker receives UKCA Mark | ||
05.09.24 | European Commission grants orphan drug designation for Vivet's VTX-806 | ||
28.08.24 | Acelyrin's izokibep for hidradenitis suppurativa reveals positive results | ||
28.08.24 | myTomorrows and Pancreatic Cancer Europe partner on clinical trials | ||
27.08.24 | National campaign launches to end prostate cancer postcode lottery | ||
27.08.24 | Improving tracking of AMR bacteria in hospitals using new genomic technique |